Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to ...
Interest in the use and impacts of glucagon-like peptide-1 receptor agonists in rheumatology has exploded over the past year, a trend that appeared to crescendo at ACR Convergence 2025. There, ...
New controllers enhance no-load performance in power supplies and lighting drivers STMicroelectronics (NYSE:STM)GENEVA, ...
Applied physicists in the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have discovered a new way to generate ultra-precise, evenly spaced "combs" of laser light on a ...
It is commonly assumed that tiny particles just go with the flow as they make their way through soil, biological tissue, and other complex materials. But a team of Yale researchers led by Professor ...
In October 2025, Praxis announced positive topline results from both Phase 3 studies in the ESSENTIAL3 program. Following a positive pre-NDA meeting with the FDA in December 2025, Praxis has submitted ...
A newly published scientific paper titled "Gene Expression Patterns in Lung Adenocarcinoma Cells in Response to Changes in ...
New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook
We were honored to receive the 2025 Clinical Trials Arena R&D Excellence Award in the Precision Endocrine Therapy category, reflecting growing awareness of the utility of (Z)-endoxifen across oncology ...
As an innovative subtype of invasive brain-computer interfaces (BCIs), the Endovascular Brain-Computer Interface (EBCI) enables electrode delivery to target brain regions via endovascular intervention ...
A wide of array of advanced controllers arrived in 2025, marked by high integration and enhanced intelligence in solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results